Wave Life Sciences Ownership | Who Owns Wave Life Sciences?
Wave Life Sciences Ownership Summary
Wave Life Sciences is owned by 87.62% institutional investors, 15.04% insiders. Ra capital management is the largest institutional shareholder, holding 11.10% of WVE shares. BB Biotech AG Ord is the top mutual fund, with 2.68% of its assets in Wave Life Sciences shares.
WVE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Wave Life Sciences | 87.62% | 15.04% | -2.66% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 18.20M | 11.10% | $133.24M |
| Adage capital partners gp | 14.57M | 8.88% | $106.64M |
| Blackrock funding, inc. /de | 10.43M | 6.36% | $76.35M |
| Blackrock | 6.74M | 5.21% | $33.63M |
| Maverick capital | 8.39M | 5.12% | $61.43M |
| Driehaus capital management | 6.30M | 3.84% | $46.10M |
| Artal group | 4.57M | 3.53% | $22.79M |
| M28 capital management lp | 5.66M | 3.45% | $41.46M |
| Fmr | 5.13M | 3.13% | $37.55M |
| Kynam capital management, lp | 4.56M | 2.78% | $33.38M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| M28 capital management lp | 5.66M | 60.97% | $41.46M |
| Pfizer | 1.88M | 3.14% | $13.72M |
| Stempoint capital lp | 2.11M | 3.09% | $15.45M |
| Kynam capital management, lp | 4.56M | 2.49% | $33.38M |
| Bioimpact capital | 1.51M | 1.80% | $11.02M |
| Ra capital management | 18.20M | 1.64% | $133.24M |
| 683 capital management | 4.15M | 1.59% | $30.38M |
| Affinity asset advisors | 2.10M | 1.34% | $15.37M |
| Siren | 3.70M | 1.06% | $27.06M |
| Maverick capital | 8.39M | 0.82% | $61.43M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 5.13M | 0.00% | 4.51M |
| Federated hermes | 3.75M | 0.05% | 3.75M |
| Stempoint capital lp | 2.11M | 3.09% | 1.21M |
| Goldman sachs group | 2.13M | 0.00% | 1.12M |
| Point72 asset management | 663.97K | 0.01% | 663.97K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Takeda pharmaceutical | - | - | -1.35M |
| Price t rowe associates inc /md/ | 4.04M | 0.00% | -1.15M |
| Silverarc capital management | - | - | -1.05M |
| Morgan stanley | 507.29K | 0.00% | -1.04M |
| Artisan partners limited partnership | 1.23M | 0.01% | -1.03M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 663.97K | 0.01% | 663.97K | $4.86M |
| Avidity partners management lp | 297.50K | 0.50% | 297.50K | $2.18M |
| Norges bank | 100.00K | 0.00% | 100.00K | $1.24M |
| Sphera funds management | 50.00K | 0.08% | 50.00K | $366.00K |
| Quantinno capital management lp | 45.05K | 0.00% | 45.05K | $329.76K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Twin peaks wealth advisors | -4.00 |
| Nelson, van denburg & campbell wealth management group | -12.00 |
| Capital performance advisors llp | -13.00 |
| Corecap advisors | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 205 | 17.14% | 143,685,835 | 5.73% | 87 | 1.28% | 96 | -7.69% | 61 | 56.41% |
| Jun 30, 2025 | 181 | -11.27% | 138,844,683 | 5.73% | 84 | 1.30% | 106 | -9.40% | 41 | -21.15% |
| Mar 31, 2025 | 202 | 6.88% | 131,254,882 | 2.11% | 80 | 0.84% | 116 | -3.33% | 51 | 34.21% |
| Dec 31, 2024 | 81 | -50.61% | 32,943,703 | -72.58% | 25 | 0.31% | 57 | -40.00% | 14 | -64.10% |
| Sep 30, 2024 | 163 | 10.88% | 118,791,972 | 26.74% | 89 | 1.71% | 95 | 15.85% | 39 | -15.22% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 4.09M | 2.68% | - |
| iShares Russell 2000 ETF | 2.70M | 1.70% | - |
| PRIMECAP Odyssey Aggressive Growth | 2.39M | 1.50% | -46.94K |
| US Small-Cap Growth II Equity Comp | 2.13M | 1.37% | 513.86K |
| T. Rowe Price New Horizons | 2.12M | 1.33% | -3.58K |
| Loomis Sayles Small Cap Growth Instl | 1.81M | 1.14% | -41.87K |
| Artisan International Small-Mid Investor | 1.51M | 0.97% | -102.46K |
| Artisan Non-U.S. Small-Mid Growth Comp | 1.51M | 0.97% | -102.46K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.28M | 0.81% | -575.53K |
| Fidelity Small Cap Index | 1.12M | 0.71% | 145.27K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 13, 2025 | Rawcliffe Adrian | - | Sell | $109.42K |
| Nov 13, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | $6.69K | |
| Aug 22, 2025 | Verdine Gregory L. | - | Sell | $100.00K |
| Aug 22, 2025 | BOLNO PAUL | President and CEO | Sell | $2.19M |
| Aug 15, 2025 | Tan Aik Na | - | Sell | $194.25K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 1 | 1 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 2 |
| 2024 Q4 | - | 8 |
WVE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools